Aims: To compare the effects of liquid and tablet formulations of levothyroxine (L-T4) in 78 newborns with congenital hypothyroidism (CH). Methods: 39 patients received liquid L-T4 (group A) and 39 patients received tablets (group B). Thyroid-stimulating hormone (TSH) and free thyroxine (fT4) were measured and L-T4 dose recorded at onset of therapy and during the first year of treatment. Developmental quotient (DQ) was assessed by Griffiths' mental development scales at 12 months of age. Results: Gestational age, birth weight, screening TSH, etiology and severity of CH, age at onset of therapy and median initial L-T4 dose were similar in both groups. fT4 concentration normalized before 10 days of treatment in all patients. Normalization of TSH concentration was achieved after 7-10 days of therapy in 87% of group A patients and in 82% of group B patients. Group A patients had significantly lower TSH values compared with those of group B at 7-10 days (p = 0.05) and 6-8 months (p = 0.043) of treatment, despite similar L-T4 dose and fT4 concentration. Mean DQ scores were within normal range in all patients. Conclusion: We confirmed the efficacy and safety of both formulations. The TSH inhibition trend when using liquid L-T4 may be linked to a higher absorption in comparison to the tablets.

Keywords:
Congenital hypothyroidism, Levothyroxine, Thyroid-stimulating hormone, Free thyroxine, Developmental quotient
1.
American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, Varma SK: Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-2303.
2.
Grussendorf M, Vaupel R, Wegscheider K: Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients. Med Klin (Munich) 2004;99:639-644.
3.
Cassio A, Monti S, Rizzello A, Bettocchi I, Baronio F, D'Addabbo G, Bal MO, Balsamo A: Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J Pediatr 2013;162:1264-1269.
4.
Ranke MB (ed): Diagnostics of Endocrine Function in Children and Adolescents. Basel, Karger, 2003, pp 93-106.
5.
Griffiths R: The Abilities of Babies. London, University of London Press, 1954.
6.
Griffiths R: The Abilities of Young Children. London, Child Development Research Centre, 1970.
7.
Griffiths R: The Abilities of Young Children. Amersham, ARICD, 1984.
8.
Griffiths' Mental Development Scales (GMDS): Pubblicato da Giunti O.S. Date di pubblicazione: Scale 0-2 anni: 1954, 1960, 1996 - Scale 2-8 anni: 1970, 1987, 2006.
9.
Virtanen M, Mäenpää J, Santavuori P, Hirvonen E, Perheentupa J: Congenital hypothyroidism: age at start of treatment versus outcome. Acta Paediatr Scand 1983;72:197-201.
10.
Kooistra L, Laane C, Vulsma T, Schellekens JM, van der Meere JJ, Kalverboer AF: Motor and cognitive development in children with congenital hypothyroidism: a long-term evaluation of the effects of neonatal treatment. J Pediatr 1994;124:903-909.
11.
Grüters A, Krude H: Update on the management of congenital hypothyroidism. Horm Res 2007;68(suppl 5):107-111.
12.
Touati G, Léger J, Toublanc JE, Farriaux JP, Stuckens C, Ponte C, David M, Rochiccioli P, Porquet D, Czernichow P: A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997;156:94-98.
13.
Von Heppe JH, Krude H, L'Allemand D, Schnabel D, Grüters A: The use of L-T4 as liquid solution improves the practicability and individualized dosage in newborns and infants with congenital hypothyroidism. J Pediatr Endocrinol Metab 2004;17:967-974.
14.
Flores-Huerta S, Hernández-Montes H, Argote RM, Villalpando S: Effects of ethanol consumption during pregnancy and lactation on the outcome and postnatal growth of the offspring. Ann Nutr Metab 1992;36:121-128.
15.
Little RE, Northstone K, Golding J, ALSPAC Study Team: Alcohol, breastfeeding, and development at 18 months. Pediatrics 2002;109:E72-2.
16.
O'Leary CM, Nassar N, Zubrick SR, Kurinczuk JJ, Stanley F, Bower C: Evidence of a complex association between dose, pattern and timing of prenatal alcohol exposure and child behaviour problems. Addiction 2010;105:74-86.
17.
Ethanol in liquid preparations intended for children. Pediatrics 1984;73:405-407.
18.
Maschi S, Fortinguerra F, Clavenna A, Bonati M: Levotiroxina in età pediatrica, formulazione e eccipienti più appropriati. Dialogo Farmaci 2007;5:133-135.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.